List of works - Jon Kroll Bjerregaard

Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer.

scientific article published on August 2010

Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer.

scientific article

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer

scientific article published on 01 May 2011

Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum.

scientific article published on 17 March 2011

Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients

scientific article published on 19 August 2012

Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.

scientific article published on 18 February 2009

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

scientific article published on 17 May 2019

In reply to Parlak and Topkan. Re: Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy.

scientific article

Incidence of pancreatic cancer in Denmark: 70 years of registration, 1943-2012.

scientific article

Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer.

scientific article published on 10 May 2009

Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group.

scientific article

MicroRNA biomarkers in whole blood for detection of pancreatic cancer

scientific article published on 01 January 2014

Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer

scientific article published on 07 October 2014

Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).

scientific article published on 17 May 2017

Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer ⬇️

scientific article published on January 12, 2012

Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy

scientific article published on 13 December 2011

S-1 (Teysuno) and gemcitabine in Caucasian patients with unresectable pancreatic adenocarcinoma

scientific article published on 31 January 2018

S-1 in combination with docetaxel and oxaliplatin in patients with advanced gastro-esophageal adenocarcinoma: two parallel phase 1/2a studies

scientific article published on 02 December 2016

The effect of aromatase inhibitors on bone metabolism.

scientific article published on January 2009

Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980-2012.

scientific article

[Cancer from the exocrine pancreas]

[Effect of aromatase inhibitors on bone metabolism]

scientific article published on 01 May 2007

List of works by Jon Kroll Bjerregaard

Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer.

Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer.

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer

Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum.

Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients

Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

In reply to Parlak and Topkan. Re: Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy.

Incidence of pancreatic cancer in Denmark: 70 years of registration, 1943-2012.

Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer.

Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group.

MicroRNA biomarkers in whole blood for detection of pancreatic cancer

Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer

Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).

Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer ⬇️

Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy

S-1 (Teysuno) and gemcitabine in Caucasian patients with unresectable pancreatic adenocarcinoma

S-1 in combination with docetaxel and oxaliplatin in patients with advanced gastro-esophageal adenocarcinoma: two parallel phase 1/2a studies

The effect of aromatase inhibitors on bone metabolism.

Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980-2012.

[Cancer from the exocrine pancreas]

[Effect of aromatase inhibitors on bone metabolism]